Science Publications

Sign Up
Sign In
Submit
Current Research in Public Health
Cite This Article Share Download PDF XML
  1. Home
  2. Journals
  3. Current Research in Public Health
  4. Archive
  5. Volume 3, Issue 1, 2024
  6. Article
Review Article Open Access April 16, 2024

Impact of Covid-19 on the Active Pharmaceutical Ingredient Supply Chain

Sourav Adak 1,*
1
New Jersey, United States
Publihed in: Current Research in Public Health (Volume 3, Issue 1, 2024)
Page(s): 6-9
DOI: 10.31586/ujpp.2024.916
Received
March 10, 2024
Revised
April 10, 2024
Accepted
April 14, 2024
Published
April 16, 2024
Keywords
Active Pharmaceutical Ingredients; Supply chain; Covid-19; Drug shortage; Production
Creative Commons

This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited.
Copyright: Copyright © The Author(s), 2024. Published by Scientific Publications
Article metrics
Views
679
Downloads
150

Cite This Article

APA Style
Adak, S. (2024). Impact of Covid-19 on the Active Pharmaceutical Ingredient Supply Chain. Current Research in Public Health, 3(1), 6-9. https://doi.org/10.31586/ujpp.2024.916
ACS Style
Adak, S. Impact of Covid-19 on the Active Pharmaceutical Ingredient Supply Chain. Current Research in Public Health 2024 3(1), 6-9. https://doi.org/10.31586/ujpp.2024.916
Chicago/Turabian Style
Adak, Sourav. 2024. "Impact of Covid-19 on the Active Pharmaceutical Ingredient Supply Chain". Current Research in Public Health 3, no. 1: 6-9. https://doi.org/10.31586/ujpp.2024.916
AMA Style
Adak S. Impact of Covid-19 on the Active Pharmaceutical Ingredient Supply Chain. Current Research in Public Health. 2024; 3(1):6-9. https://doi.org/10.31586/ujpp.2024.916 
@Article{crph916,
AUTHOR = {Adak, Sourav},
TITLE = {Impact of Covid-19 on the Active Pharmaceutical Ingredient Supply Chain},
JOURNAL = {Current Research in Public Health},
VOLUME = {3},
YEAR = {2024},
NUMBER = {1},
PAGES = {6-9},
URL = {https://www.scipublications.com/journal/index.php/UJPP/article/view/916},
ISSN = {2831-5162},
DOI = {10.31586/ujpp.2024.916},
ABSTRACT = {An increasing number of adverse events are raising concern in the pharmaceutical supply chain due to contaminated active pharmaceutical ingredients (APIs). Most of the active pharmaceutical ingredients are not currently under the scope of environmental regulations, despite their negative impact on human health and the environment. API's life cycle plays a significant role in identifying potential supply chain sources and determining their impact on the environment. The Covid-19 pandemic's intermittent manufacturing interruptions and the increase in the frequency of drug shortages over the past ten years have sparked worries about how resilient the world's drug supply chains are. Many clinical trials were conducted on patients with COVID-19 during the SARS-CoV-2 pandemic and resulted in millions of deaths globally by 2022.},
}
%0 Journal Article
%A Adak, Sourav
%D 2024
%J Current Research in Public Health

%@ 2831-5162
%V 3
%N 1
%P 6-9

%T Impact of Covid-19 on the Active Pharmaceutical Ingredient Supply Chain
%M doi:10.31586/ujpp.2024.916
%U https://www.scipublications.com/journal/index.php/UJPP/article/view/916

TY  - JOUR
AU  - Adak, Sourav
TI  - Impact of Covid-19 on the Active Pharmaceutical Ingredient Supply Chain
T2  - Current Research in Public Health
PY  - 2024
VL  - 3
IS  - 1
SN  - 2831-5162
SP  - 6
EP  - 9
UR  - https://www.scipublications.com/journal/index.php/UJPP/article/view/916
AB  - An increasing number of adverse events are raising concern in the pharmaceutical supply chain due to contaminated active pharmaceutical ingredients (APIs). Most of the active pharmaceutical ingredients are not currently under the scope of environmental regulations, despite their negative impact on human health and the environment. API's life cycle plays a significant role in identifying potential supply chain sources and determining their impact on the environment. The Covid-19 pandemic's intermittent manufacturing interruptions and the increase in the frequency of drug shortages over the past ten years have sparked worries about how resilient the world's drug supply chains are. Many clinical trials were conducted on patients with COVID-19 during the SARS-CoV-2 pandemic and resulted in millions of deaths globally by 2022.
DO  - Impact of Covid-19 on the Active Pharmaceutical Ingredient Supply Chain
TI  - 10.31586/ujpp.2024.916
ER  -